The findings extend reports linking AMOT with EDS in OSA patients, and provide direct evidence that perturbation of BIRC3 and LGALS3 signaling may play an important role in the mediation of hypertension and CKD in OSA patients, respectively. The gene discussed is BIRC3; the disease is hypertensive disorder.